Advertisement

Nucleoside Analogues in the Chemotherapy of Viral Infections

Recent Developments
  • Erik De Clercq
Chapter
Part of the Applied Virology Research book series (AOTP, volume 1)

Abstract

Various nucleoside analogues with promising antiviral activity were recently described. They can be divided into two classes: pyrimidine nucleoside analogues, and purine nucleoside analogues.

Keywords

Herpes Simplex Virus Type Nucleoside Analogue African Swine Fever Virus Infectious Pancreatic Necrosis Virus Pyrimidine Nucleoside 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Baba, M., Mori, S., Shigeta, S., and De Clercq, E. (1987). Antimicrob. Agents Chemother. 31, 337–339.PubMedCrossRefGoogle Scholar
  2. Ben-Efraim, S., Shoval, S., and De Clercq, E. (1986). Brit. J. Cancer, 54, 847–852.PubMedCrossRefGoogle Scholar
  3. Benoit, Y., Laureys, G., Delbeke, M.-J., and De Clercq, E. (1985). Eur. J. Pediatr. 143, 198–202.PubMedCrossRefGoogle Scholar
  4. Borchardt, R. T., Keller, B. T., and Patel-Thombre, U. (1984). J. Biol. Chem. 259, 4353–4358.PubMedGoogle Scholar
  5. Bussereau, F., Chermann, J. C., De Clercq, E., and Hannoun, C. (1983). Ann. Virol, (lnst. Pasteur) 134E, 127–134.CrossRefGoogle Scholar
  6. Busson, R., Colla, L., Vanderhaeghe, H., and De Clercq, E. (1981). Nucleic Acids Res. (Symposium Series No. 9) 9, 49–52.Google Scholar
  7. Colla, L., Herdewijn, P., De Clercq, E., Balzarini, J., and Vanderhaeghe, H. (1985). Eur. J. Med. Chem. 20, 295–301.Google Scholar
  8. Cooney, D. A., Dalai, M., Mitsuya, H., McMahon, J. B., Nadkarni, M., Balzarini, J., Broder, S., and Johns, D. G. (1986). Biochem. Pharmacol. 35, 2065–2068.PubMedCrossRefGoogle Scholar
  9. De Clercq, E. (1982). Antimicrob. Agents Chemother. 21, 661–663.PubMedCrossRefGoogle Scholar
  10. De Clercq, E. (1984). J. Antimicrob. Chemother. 14 (Suppl. A), 85–95.PubMedCrossRefGoogle Scholar
  11. De Clercq, E. (1985). Antimicrob. Agents Chemother. 28, 84–89.PubMedCrossRefGoogle Scholar
  12. De Clercq, E., and Cools, M. (1985). Biochem. Biophys. Res. Commun. 129, 306–311.PubMedCrossRefGoogle Scholar
  13. De Clercq, E., and Holý, A. (1979). J. Med. Chem. 22, 510–513.PubMedCrossRefGoogle Scholar
  14. De Clercq, E., and Holý, A. (1985). J. Med. Chem. 28, 282–287.PubMedCrossRefGoogle Scholar
  15. De Clercq, E., and Montgomery, J. A. (1983). Antiviral Res. 3, 17–24.PubMedCrossRefGoogle Scholar
  16. De Clercq, E., and Rosenwirth, B. (1985). Antimicrob. Agents Chemother. 28, 246–251.PubMedCrossRefGoogle Scholar
  17. De Clercq, E., and Shugar, D. (1975). Biochem. Pharmacol. 24, 1073–1078.PubMedCrossRefGoogle Scholar
  18. De Clercq, E., and Walker, R. T. (1984). Pharmac. Ther. 26, 1–44.CrossRefGoogle Scholar
  19. De Clercq, E., Descamps, J., De Somer, P., and Holý, A. (1978). Science 200, 563–565.CrossRefGoogle Scholar
  20. De Clercq, E., Descamps, J., De Somer, P., Barr, P. J., Jones, A. S., and Walker, R. T. (1979). Proc. Natl. Acad. Sci. USA 76, 2947–2951.PubMedCrossRefGoogle Scholar
  21. De Clercq, E., Balzarini, J., Descamps, J., and Eckstein, F. (1980). Biochem. Pharmacol. 29, 1849–1851.PubMedCrossRefGoogle Scholar
  22. De Clercq, E., Balzarini, J., Descamps, J., Huang, G.-F., Torrence, P. F., Bergstrom, D. E., Jones, A. S., Serafinowski, P., Verhelst, G., and Walker, R. T. (1982a). Mol. Pharmacol. 21, 217–223.PubMedGoogle Scholar
  23. De Clercq, E., Busson, R., Colla, L., Descamps, J., Balzarini, J., and Vanderhaeghe, H. (1982b). In Current Chemotherapy and Immunotherapy (P. Periti and G. G. Grassi, eds.), Vol. II, pp. 1062–1064, American Society for Microbiology, Washington, D. C.Google Scholar
  24. De Clercq, E., Descamps, J., Balzarini, J., Fukui, T., and Allaudeen, H. S. (1983). Biochem. J. 211, 439–445.PubMedGoogle Scholar
  25. De Clercq, E., Bergstrom, D. E., Holý, A., and Montgomery, J. A. (1984). Antiviral Res. 4, 119–133.PubMedCrossRefGoogle Scholar
  26. De Clercq, E., Balzarini, J., Bernaerts, R., Herdewijn, P., and Verbruggen, A. (1985a). Biochem. Biophys. Res. Commun. 126, 397–403.PubMedCrossRefGoogle Scholar
  27. De Clercq, E., Benoit, Y., Laureys, G., and Delbeke, M. J. (1985b). In Herpes Viruses and Virus Chemotherapy (R. Kono, ed.), pp. 49–52, Elsevier Science Publishers, Amsterdam.Google Scholar
  28. De Clercq, E., Bernaerts, R., Balzarini, J., Herdewijn, P., and Verbruggen, A. (1985c). J. Biol. Chem. 260, 10621–10628.PubMedGoogle Scholar
  29. De Clercq, E., Desgranges, C., Herdewijn, P., Sim, I. S., and Walker, R. T. (1985d). In Proceedings of the Eighth International Symposium on Medicinal Chemistry (R. Dahlbom, and J. L. G. Nilsson, eds.), Vol. 1, pp. 198–210, Swedish Pharmaceutical Press, Stockholm.Google Scholar
  30. De Clercq, E., Desgranges, C., Herdewijn, P., Sim, I. S., Jones, A. S., McLean, M. J., and Walker, R. T. (1986a). J. Med. Chem. 29, 213–217.PubMedCrossRefGoogle Scholar
  31. De Clercq, E., Holý, A., Rosenberg, I., Sakuma, T., Balzarini, J., and Maudgal, P. C. (1986). Nature (London) 323, 464–467.CrossRefGoogle Scholar
  32. Desgranges, C., Razaka, G., Rabaud, M., Bricaud, H., Balzarini, J., and De Clercq, E. (1983). Biochem. Pharmacol. 32, 3583–3590.PubMedCrossRefGoogle Scholar
  33. Desgranges, C., Razaka, G., Drouillet, F., Bricaud, H., Herdewijn, P., and De Clercq, E. (1984). Nucleic Acids Res. 12, 2081–2090.PubMedCrossRefGoogle Scholar
  34. Desgranges, C., Razaka, G., Bricaud, H., and De Clercq, E. (1985). Biochem. Pharmacol. 34, 405–406.CrossRefGoogle Scholar
  35. Desgranges, C., De Clercq, E., Razaka, G., Drouillet, F., Belloc, I., and Bricaud, H. (1986a). Biochem. Pharmacol. 35, 1647–1653.PubMedCrossRefGoogle Scholar
  36. Desgranges, C., Razaka, G., De Clercq, E., Herdewijn, P., Balzarini, J., Drouillet, F., and Bricaud, H. (1986). Cancer Res. 46, 1094–1101.PubMedGoogle Scholar
  37. Field, A. K., Davies, M. E. M., DeWitt, C. M., Perry, H. C., Schofield, T. L., Karkas, J. D., Germershausen, J., Wagner, A. F., Cantone, C. L., MacCoss, M., and Tolman, R. L. (1986). Antiviral Res. 6, 329–341.PubMedCrossRefGoogle Scholar
  38. Griengl, H., Bodenteich, M., Hayden, W., Wanek, E., Streicher, W., Stutz, P., Bachmaer, H., Ghazzouli, I., and Rosenwirth, B. (1985). J. Med. Chem. 28, 1679–1684.PubMedCrossRefGoogle Scholar
  39. Herdewijn, P., De Clercq, E., Balzarini, J., and Vanderhaeghe, H. (1985). J. Med. Chem. 28, 550–555.PubMedCrossRefGoogle Scholar
  40. Holý, A., Votruba, I., and De Clercq, E. (1984). Collect. Czechoslov. Chem. Commun. 50, 262–279.CrossRefGoogle Scholar
  41. Horwitz, J. P., Chua, J., and Noel, M. (1964). J. Org. Chem. 29, 2076–2078.CrossRefGoogle Scholar
  42. Kara, J., Vácha, P., and Holý, A. (1979). FEBS Lett. 107, 187–192.PubMedCrossRefGoogle Scholar
  43. Kitaoka, S., Konno, T., and De Clercq, E. (1986). Antiviral Res. 6, 57–65.PubMedCrossRefGoogle Scholar
  44. Lin, J.-C., Smith, M. C., Choi, E. L, De Clercq, E., Verbruggen, A., and Pagano, J. S. (1985). Antiviral Res. (Suppl. No. 1) 1, 121–126.CrossRefGoogle Scholar
  45. Lin, T.-S., and Prusoff, W. H. (1978). J. Med. Chem. 21, 109–112.PubMedCrossRefGoogle Scholar
  46. Machida, H., Kuninaka, A., and Yoshino, H. (1982). Antimicrob. Agents Chemother. 21, 358–361.PubMedCrossRefGoogle Scholar
  47. Machida, H., and Sakata, S. (1984). Antiviral Res. 4, 135–141.PubMedCrossRefGoogle Scholar
  48. Machida, H., Sakata, S., Kuninaka, A., and Yoshino, H. (1981). Antimicrob. Agents Chemother. 20, 47–52.PubMedCrossRefGoogle Scholar
  49. Maudgal, P. C., and De Clercq, E. (1985). Arch. Ophthalmol. 103, 1393–1397.PubMedCrossRefGoogle Scholar
  50. Maudgal, P. C., De Clercq, E., Bernaerts, R., Dieltiens, M., Breemersch, M., and Van Eeckhoutte, L. (1986a). Invest. Ophthalmol. Vis. Sci. 27, 1453–1458.PubMedGoogle Scholar
  51. Maudgal, P. C., De Clercq, E., and Huyghe, P. (1987). Invest. Opthalmol. Vis. Sci. 28, 243–248.Google Scholar
  52. Maudgal, P. C., De Clercq, E., and Missotten, L. (1984). Antiviral Res. 4, 281–291.PubMedCrossRefGoogle Scholar
  53. Maudgal, P. C., Dieltiens, M., De Clercq, E., and Missotten, L. (6a). In Herpetic Eye Diseases (P. C. Maudgal and L. Missotten, eds.), pp. 247–256, W. Junk Publishers, Dordrecht.Google Scholar
  54. Maudgal, P. C., Dieltiens, M., De Clercq, E., and Missotten, L. (1985). In Herpetic Eye Diseases (P. C. Maudgal and L. Missotten, eds.), pp. 403–411, W. Junk Publishers, Dordrecht.CrossRefGoogle Scholar
  55. Mitsuya, H., and Broder, S. (1986). Proc. Natl. Acad. Sci. USA 83, 1911–1915.PubMedCrossRefGoogle Scholar
  56. Mitsuya, H., Weinhold, K. J., Furman, P. A., St. Clair, M. H., Nusinoff Lehrman, S., Gallo, R. C., Bolognesi, D., Barry, D. W., and Broder, S. (1985). Proc. Natl. Acad. Sci. USA 82, 7096–7100.PubMedCrossRefGoogle Scholar
  57. Montgomery, J. A., Clayton, S. J., Thomas, H. J., Shannon, W. M., Arnett, G., Bodner, A. J., Kim, I.-K., Cantoni, G. L., and Chiang, P. K. (1982). J. Med. Chem. 25, 626–629.PubMedCrossRefGoogle Scholar
  58. Osterhaus, A. D. M. E., Groen, J., and De Clercq, E. (1987). Antiviral Res. 7, 221–226.PubMedCrossRefGoogle Scholar
  59. Schinazi, R. F., Scott, R. T., Peters, J., Rice, V., and Nahmias, A. J. (1985). Antimicrob. Agents Chemother. 28, 552–560.PubMedCrossRefGoogle Scholar
  60. Smee, D. F., Sidwell, R. W., Clark, S. M., Barnett, B. B., and Spendlove, R. S. (1982). Antimicrob. Agents Chemother. 21, 66–73.PubMedCrossRefGoogle Scholar
  61. Sodja, I., and Holý, A. (1980). Acta Virol. 24, 317–324.PubMedGoogle Scholar
  62. Soike, K. F., Baskin, G., Cantrell, C., and Gerone, P. (1984). Antiviral Res. 4, 245–257.PubMedCrossRefGoogle Scholar
  63. Spruance, S. L., Freeman, D. J., and Sheth, N. V. (1985). Antimicrob. Agents Chemother. 28, 103–106.PubMedCrossRefGoogle Scholar
  64. Reefschläger, J., Wutzler, P., Thiel, K.-D., and Herrmann, G. (1986). Antiviral Res. 6, 83–93.PubMedCrossRefGoogle Scholar
  65. Rosenwirth, B., Griengl, H., Wanek, E., and De Clercq, E. (1985). Antiviral Res. (Suppl. No. 1) 1, 21–28.CrossRefGoogle Scholar
  66. Tolman, R. L., Field, A. K., Karkas, T. D., Wagner, A. F., Germershausen, J., Crumpacker, C., and Scolnick, E. M. (1985). Biochem. Biophys. Res. Commun. 128, 1329–1335.PubMedCrossRefGoogle Scholar
  67. Tricot, G., De Clercq, E., Boogaerts, M. A., and Verwilghen, R. L. (1986). J. Med. Virol. 18, 11–20.PubMedCrossRefGoogle Scholar
  68. Vinckier, F., Boogaerts, M., Declerck, D., and De} Clercq, E. (1986). J. Oral Maxillofacial Surg. (in press)Google Scholar
  69. Votruba, L, and Holý, A. (1980). Collect. Czechoslov. Chem. Commun. 45, 3039–3044.Google Scholar
  70. Waqar, M. A., Evans, M. J., Manly, K. F., Hughes, R. G., and Huberman, J. A. (1984). J. Cell. Physiol. 121, 402–408.PubMedCrossRefGoogle Scholar
  71. Wildiers, J., and De Clercq, E. (1984). Eur. J. Cancer Clin. Oncol. 20, 471–476.PubMedCrossRefGoogle Scholar
  72. Yarchoan, R., Klecker, R. W., Weinhold, K. J., Markham, P. D., Lyerly, H. K., Durack, D. T., Gelmann, E., Nusinoff Lehrman, S., Blum, R. M., Barry, D. W., Shearer, G. M., Fischl, M. A., Mitsuya, H., Gallo, R. C., Collins, J. M., Bolognesi, D. P., Myers, C. E., and Broder, S. (1986). Lancet 1, 575–580.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1988

Authors and Affiliations

  • Erik De Clercq
    • 1
  1. 1.Rega Institute for Medical ResearchThe Catholic University of LouvainLouvainBelgium

Personalised recommendations